Elevance Health’s Digital Equity Push Reframes Virtual Care And Investor Narrative
Elevance Health Inc. (NYSE:ELV) Shows Strong Technical Breakout Setup with Perfect 10/10 Quality Rating
Elevance Health Stock: Is ELV Underperforming the Health Care Sector?
Truist Securities Maintains Buy on Elevance Health, Raises Price Target to $450
Elevance again avoids Medicare Advantage sanctions, but threat remains
Elevance Health (ELV): One of the Best Undervalued Stocks to Buy According to the Financial Media
Evaluating Elevance Health (ELV) Valuation As Shares Trade Near Fair Value And Peer P/E Discounts
Bullish Elevance Health Insiders Loaded Up On US$3.68m Of Stock
UBS Reaffirms Buy on Elevance Health (ELV) Amid Stronger Industry Trends
What Elevance Health (ELV)'s Raised EPS Outlook and Insider Stock Sale Means For Shareholders
Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue?
Are Wall Street Analysts Predicting Elevance Stock Will Climb or Sink?
UBS Maintains Buy on Elevance Health, Raises Price Target to $460
Deutsche Bank Upgrades Elevance Health (ELV)
Wall Street sees new upswing for health insurers after years of margin pressure
Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $435
Deutsche Bank Upgrades Elevance Health to Buy, Raises Price Target to $498
U.S. Health Insurers Raise EPS Estimates After Strong Q1'26, Higher Medicare Rates
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.